Reve Technologies, Inc. Company Review & Valuation

BSSP
OTC Markets
Latest Price
0.00USD
Market Capitalization
260.32kUSD

About Reve Technologies, Inc.

Reve Technologies, Inc., a drug development company, provides advanced therapeutics for the treatment of cancer.

It offers irreversible pepsin fraction (IPF), a therapeutic platform technology that is used to facilitate a range of applications.

The company's solution is also used for the treatment of autoimmune diseases, such as cirrhosis and Hepatitis C. The company was founded in 2010 and is based in San Clemente, California.

Industry
Biotechnology
HQ Location
San Clemente, California

Stock Price

Price data not available for Reve Technologies, Inc..

Performance

Please login or create a free account to view the contents of this section.

Financial Reports

Please login or create a free account to view the contents of this section.

Similar Companies

back to top

Valuu.io

Valuu provides insights and tools for self-directed stock investors. It enables you to easily find, valuate and track your stock investments with the help of reliable financial data and transparent analysis tools.

Disclaimer: This website is a data portal, which aggregates information about public companies. It is not a stock broker and does not give advice concerning specific investment decisions or tax or legal advice. All data is provided "as-is" with no guarantee for correctness and/or completeness. All company names, logos, and brands are intellectual property of their respective owners. The use of them is for editorial purposes only and does not imply any affiliation or endorsement.
© 2019-2021 Valuu Analytics Sàrl